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INTRODUCTIONAneurysmal and occlusive vascular arterial disease has underdiagnosed and undertreated with respect to arterial
long been associated with the smoking, overweight, hyper-
tensive, and Caucasian male with venous disease being
more aligned with females. Yet stop to consider the
following: (1) hypertension affects 75% of women over
the age of 70,1 (2) 21 million women smoked in the United
States in 2008 compared with 24 million men,2 and (3)
58% of Caucasian women, 80% of African-American
women, and 74% of Hispanic-American women are over-
weight or obese.3 According to the Administration on
Aging,4 older Americans (65þ years) numbered 40.4
million in 2010, representing a 15.3% increase since
2000. Current projections are for greater than 36% increase
over the next decade to 55 million in 2020. Women reach-
ing age 65 have an average additional life expectancy of
20.0 years compared with 17.3 years for males. Older
women outnumber older men at 23.0 million compared
to 17.5 million men with nearly half of these women living
alone. Those 85þ years of age are expected to increase by
19% over the next decade from 5.5 million in 2010 to 6.6
million in 2020. With nearly half of older women living at
home, one can envision the potential positive impact mini-
mally invasive options for vascular disease can have on these
individuals in keeping them out of nursing homes and
extended care facilities.
Vascular disease behaves differently in women com-
pared with men on both a physiologic and clinical level.
Women often present late in their vascular disease course
at a time when the disease is more extensive and potentially
after a time when minimally invasive options may not be
possible. This may be in part from lack of recognition on
the part of patient or physician. Claudication and rest pain
may be mistaken for varicose veins, diabetic neuropathy
chalked up to “just getting old,” symptomatic carotid
stenosis disguised as carpal tunnel syndrome, and symptom-
atic abdominal aortic aneurysms (AAAs) lumbar disc
disease.
We have been slow to recognize peripheral vascular
disease in women analogous to the inability to effectively
diagnose coronary artery disease in females that plagued
clinicians in previous decades. Most of peripheral arterial
disease (PAD) research and clinical trials have focused on
men, thus, our knowledge of the disease process in women
is limited. Drs Kibbe, Teodorescu, and Vavra review what
we do know with regard to prevalence, risk factors, presen-
tation, treatment, and outcomes of PAD in women
compared with men. Clearly women continue to beAuthor conﬂict of interest: none.
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numbers mentioned above with regard to the increasing
population of elderly women, it will be important to
develop more sex-speciﬁc cardiovascular risk factor modiﬁ-
cations in our efforts to manage PAD.
The incidence of AAAs in women rises with advancing
age. Though routine screening is not advocated for
women, rupture rates are reportedly higher in women
compared with men. The United Kingdom small aneurysm
trial revealed that women have a threefold higher rupture
rate than men, even after adjustment for age, initial
AAA diameter, body mass index, or height. 5 Drs Halpern
and Starr outline what we currently know from the litera-
ture with regard to management of AAAs in women
compared with men. Though outcomes remain compa-
rable in the thoracic aorta between men and women, Drs
Starr and Huynh point out the ongoing need for industry
to continue to work on device proﬁle and conformability
to accommodate smaller access vessels and aortas in
women.
Venous disease was historically ignored or considered
less clinically important in the days of vein stripping. A
disease with higher incidence in women compared with
men in the earlier decades of life, venous insufﬁciency
management was often invasive and morbid if undertaken
at all. Compression management and leg elevation was
often the pat answer for those patients seeking relief
and not wishing to undertake the prolonged recovery
time after removal of the great saphenous vein. Drs
Lohr and Bush present a comprehensive review of
management of venous disease in women, with Drs
Ozvath and Moore highlighting an often unrecognized
cause of lower extremity venous insufﬁciency e venous
occlusive disease of the inferior vena cava and iliofemoral
venous segments.
Dialysis access in women is challenging. The natural
assumption would be smaller vessel size, however, this
has not been borne out in the literature. Failure for access
maturation, steal syndrome, and ischemic monomelic
neuropathy occur more frequently in women, though the
mechanisms are unknown. The progression of nondiabetic
chronic kidney disease is notably slower in women
compared with men at the same creatinine level. Authors
Pounds and Teodorescu highlight many of these points
in detail.
Perhaps one of the most vexing and challenging
patients seen on any busy vascular surgeon’s clinic schedule
is the woman presenting with palpable extremity pulses and
cool, cyanotic digits. The vascular arteritides in women
are well delineated by Drs Socvell, Gallagher, and Trucci.
We only wish the treatment modalities were so readily
apparent.1S
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2S Reed et al April Supplement 2013Efforts to promote awareness of vascular disease in
women begin at the grassroots level. Women, men, and
vascular surgeons need to reach out to their local commu-
nity, to internists, family practitioners, and gynecologists. It
is with this collective effort that we can begin to impact on
the morbidity and mortality that befalls women with a rate
more alarming than breast cancer.
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